Comments on: New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting

Comments on: New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting https://www.novumpr.nl/2018/04/24/new-analyses-from-pivotal-phase-iii-trials-of-oral-ozanimod-in-relapsing-multiple-sclerosis-to-be-presented-at-the-2018-american-academy-of-neurology-annual-meeting/?utm_source=rss&utm_medium=rss&utm_campaign=new-analyses-from-pivotal-phase-iii-trials-of-oral-ozanimod-in-relapsing-multiple-sclerosis-to-be-presented-at-the-2018-american-academy-of-neurology-annual-meeting NovumPR press releases Tue, 24 Apr 2018 12:12:13 +0000 hourly 1 https://wordpress.org/?v=6.8.3